Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes
2019 · Stem Cell Research & Therapy · 101 citations
https://doi.org/10.1186/s13287-019-1362-2
S
Shengxian Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
148
Papers
2.6K
Citations
29
h-index
65
i10-index
Shengxian Li is an academic researcher from Qingdao University. The author has contributed to research in topics: Ovarian function and disorders & Lipid metabolism and disorders & Liver Disease Diagnosis and Treatment. The author has an h-index of 29, co-authored 126 publications.
ORCID: 0000-0003-2671-4733Papers by this author
worksSteroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
2017 · Scientific Reports · 59 citations
https://doi.org/10.1038/s41598-017-14534-2
Emphysematous pyelonephritis and cystitis: A case report and literature review
2018 · Journal of International Medical Research · 33 citations
https://doi.org/10.1177/0300060518770341
Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study
2021 · Frontiers in Endocrinology · 20 citations
https://doi.org/10.3389/fendo.2021.611526
Organ-specific extracellular matrix directs trans-differentiation of mesenchymal stem cells and formation of salivary gland-like organoids in vivo
2022 · Stem Cell Research & Therapy · 17 citations
https://doi.org/10.1186/s13287-022-02993-y
Secreted EMC10 is upregulated in human obesity and its neutralizing antibody prevents diet-induced obesity in mice
2022 · Nature Communications · 17 citations
https://doi.org/10.1038/s41467-022-34259-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat